Thomas Burke is listed as an executive officer and director on 3 SEC Form D filings by 2 issuers between Feb 2017 and Mar 2025: VAIL SCIENTIFIC, INC. (Bloomington, MN — biotechnology — 2023–2025; $7M reported sold to 13 investors) and HENNEPIN LIFE SCIENCES, LLC (Plymouth, MN — biotechnology — 2017; $1.85M reported sold to 11 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 8 years. Across those companies the filings report $8.85M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Thomas Burke and found 11 differences, 1 worth asking the sponsor about: Form D filed 81 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.